远大医药(00512.HK)治疗胃肠胰腺神经内分泌肿瘤新药获批内地三期临床

阿斯达克财经03-25

远大医药(00512.HK) 公布，集团用于治疗胃肠胰腺神经内分泌肿瘤的全球创新放射性核素偶联药物(RDC)ITM-11，近日已获得中国国家药品监督管理局批准开展三期临床研究。集团指，研究拟在中国、美国、英国、法国、德国、澳洲等全球11个国家入组至少202名患者。(ek/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-22 16:25。)AASTOCKS新闻

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2422582130?lang=zh_CN&edition=full","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190311162624473_s.jpg","is_english":false,"pubTime":"2024-03-25 08:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2422582130","market":"other","top_or_hot":-1,"title":"远大医药(00512.HK)治疗胃肠胰腺神经内分泌肿瘤新药获批内地三期临床","media":"阿斯达克财经","content":"<div>\n<p>远大医药(00512.HK) 公布，集团用于治疗胃肠胰腺神经内分泌肿瘤的全球创新放射性核素偶联药物(RDC)ITM-11，近日已获得中国国家药品监督管理局批准开展三期临床研究。集团指，研究拟在中国、美国、英国、法国、德国、澳洲等全球11个国家入组至少202名患者。(ek/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-22 16:25。)AASTOCKS新闻</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1336371/latest-news/AAFN\">网页链接</a>\n\n</div>\n","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>远大医药(00512.HK)治疗胃肠胰腺神经内分泌肿瘤新药获批内地三期临床</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n远大医药(00512.HK)治疗胃肠胰腺神经内分泌肿瘤新药获批内地三期临床\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-25 08:59 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1336371/latest-news/AAFN><strong>阿斯达克财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>远大医药(00512.HK) 公布，集团用于治疗胃肠胰腺神经内分泌肿瘤的全球创新放射性核素偶联药物(RDC)ITM-11，近日已获得中国国家药品监督管理局批准开展三期临床研究。集团指，研究拟在中国、美国、英国、法国、德国、澳洲等全球11个国家入组至少202名患者。(ek/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-22 16:25。)AASTOCKS新闻</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1336371/latest-news/AAFN\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00512","symbol_name":"远大医药","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1336371/latest-news/AAFN","article_id":"2422582130","we_media_id":null,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190311162624473_s.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422582130","pubTimestamp":1711328340,"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"远大医药(00512.HK) 公布，集团用于治疗胃肠胰腺神经内分泌肿瘤的全球创新放射性核素偶联药物(RDC)ITM-11，近日已获得中国国家药品监督管理局批准开展三期临床研究。集团指，研究拟在中国、美国、英国、法国、德国、澳洲等全球11个国家入组至少202名患者。(ek/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-22 16:25。)AASTOCKS新闻","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"00512":"远大医药","BK1191":"制药"},"translate_title":"Yuanda Medicine (00512. HK), a new drug for treating gastrointestinal and pancreatic neuroendocrine tumors, was approved for Phase III clinical treatment in mainland China","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00512":1},"content_text":"远大医药(00512.HK) 公布，集团用于治疗胃肠胰腺神经内分泌肿瘤的全球创新放射性核素偶联药物(RDC)ITM-11，近日已获得中国国家药品监督管理局批准开展三期临床研究。集团指，研究拟在中国、美国、英国、法国、德国、澳洲等全球11个国家入组至少202名患者。(ek/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-22 16:25。)AASTOCKS新闻","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422582130"}